TLR3 Deficiency in Patients with Herpes Simplex Encephalitis.

Shen-Ying Zhang,Emmanuelle Jouanguy,Sophie Ugolini,Asma Smahi,Gaelle Elain,Pedro Romero,David Segal,Vanessa Sancho-Shimizu,Lazaro Lorenzo,Anne Puel,Capucine Picard,Ariane Chapgier,Sabine Plancoulaine,Matthias Titeux,Celine Cognet,Horst von Bernuth,Cheng-Lung Ku,Armanda Casrouge,Xin-Xin Zhang,Luis Barreiro,Joshua Leonard,Claire Hamilton,Pierre Lebon,Benedicte Heron,Louis Vallee,Lluis Quintana-Murci,Alain Hovnanian,Flore Rozenberg,Eric Vivier,Frederic Geissmann,Marc Tardieu,Laurent Abel,Jean-Laurent Casanova
DOI: https://doi.org/10.1126/science.1139522
IF: 56.9
2007-01-01
Science
Abstract:Some Toll and Toll-like receptors (TLRs) provide immunity to experimental infections in animal models, but their contribution to host defense in natural ecosystems is unknown. We report a dominant-negative TLR3 allele in otherwise healthy children with herpes simplex virus 1 (HSV-1) encephalitis. TLR3 is expressed in the central nervous system (CNS), where it is required to control HSV-1, which spreads from the epithelium to the CNS via cranial nerves. TLR3 is also expressed in epithelial and dendritic cells, which apparently use TLR3-independent pathways to prevent further dissemination of HSV-1 and to provide resistance to other pathogens in TLR3-deficient patients. Human TLR3 appears to be redundant in host defense to most microbes but is vital for natural immunity to HSV-1 in the CNS, which suggests that neurotropic viruses have contributed to the evolutionary maintenance of TLR3.
What problem does this paper attempt to address?